Mohd Rizwan Jameel

Mr. Mohd Rizwan Jameel

Jamia Millia Islamia, New Delhi, Delhi, International
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2022 in Agronomy
Verified
Journal Article
Open access
PDF file
MJMohd Rizwan Jameel
Mohd Rizwan Jameel
Zubaida  AnsariZubaida Ansari
Zubaida Ansari
Arwa Abdulkreem AL-HuqailArwa Abdulkreem AL-Huqail
Arwa Abdulkreem AL-Huqail
SNSheeba Naaz
Sheeba Naaz
MQM. Irfan Qureshi
M. Irfan Qureshi
In the present study, the selected rice (Oryza sativa cv. indica) was genetically modified to increase the amylose content in the seeds. The ‘CRISPR-Cas9’ genome-editing tool was used to knock out three isoforms of soluble starch synthase (SSS) viz. SSSII-1, SSSII-2 and SSSII-3. A genetic transformation vector designed with appropriate gRNAs, Cas9, and antibiotic resistance was used to create SSS knockout mutants to enrich the content of amylose. Putative rice mutants were developed with high amylose content in the seeds of up to 63% as compared to 23% in the wild types (control). Rice with a low Glycemic Index (GI) value and high amylose content rice is preferred to avoid a sudden rise in glucose in the bloodstream. The frequencies of bi-allelic or homozygous transgenic lines of SSSII-1, SSSII-2, and SSSII-3 in the first generation were tested via the Mendelian fashion of segregated bi-allelic lines in the T1 generation of the putative rice mutants. The T1 generation segregation showed a frame-shift mutation. A molecular characterization of the putative mutants successfully demonstrated the development of a Cas9-free rice mutant with a higher amount of amylose in the rice.

31 May 2022 in Bioinformation
Verified
Journal Article
Open access
MJMohd Rizwan Jameel
Mohd Rizwan Jameel
Acinetobacter baumannii (AB) is one of the most common causes of nosocomial infections. Therefore, it is of interest to design and develop drugs against Acinetobacter baumannii. A strain of AB showing MIC 32 μg/ml against colistin was isolated from a hospital environment in Iran. Hence, we document data to glean insights from the molecular docking analysis of colistin with the PmrA protein from this bacterium.

30 December 2025 in Journal of Analytical Oncology
Verified
Journal Article
Open access
MJMohd Rizwan Jameel
Mohd Rizwan Jameel
AAAmar Arora
Amar Arora
PMPrem Shankar Mishra
Prem Shankar Mishra
HJHina Jameel
Hina Jameel
MMMudassir Jan Makhdoomi
Mudassir Jan Makhdoomi
ASAbid Ali Sheikh
Abid Ali Sheikh
Lung cancer persists as the leading cause of cancer-related mortality globally, largely due to late detection, genomic complexity, and limited durability of existing therapeutic interventions. The integration of CRISPR/Cas9 gene-editing systems with biomarker-driven therapeutic strategies represents a transformative advance in precision oncology. Biomarkers—including genetic mutations, epigenetic alterations, protein signatures, and circulating analytes—enable early detection, patient stratification, and dynamic monitoring of therapeutic response. CRISPR/Cas9 offers a unique opportunity to directly reprogram these biomarkers or the pathways regulating them, enhancing tumor immunogenicity, reversing immune evasion mechanisms, and strengthening anti-tumor immune responses. Preclinical models demonstrate that CRISPR-mediated biomarker editing can restore antigen presentation, augment T-cell cytotoxicity, sensitize resistant tumors to immunotherapy, and improve tumor regression. Early clinical trials further validate the feasibility and safety of CRISPR-engineered immune cells in patients. However, major challenges persist, including off-target editing, inefficient delivery to solid tumors, tumor microenvironment–mediated suppression, and ethical considerations linked to genome manipulation. Rapid advancements in editing fidelity, lipid nanoparticle systems, viral vectors, engineered vesicles, high-throughput biomarker discovery, and artificial intelligence–assisted CRISPR design are expected to accelerate clinical translation. This review synthesizes the current landscape, mechanistic underpinnings, emerging applications, and future directions of CRISPR/Cas9-enabled biomarker engineering for lung cancer immunotherapy, positioning this technology as a cornerstone of next-generation personalized oncology.

19 June 2026
Verified
Book Chapter
Closed access
KAKripamoy Aguan
Kripamoy Aguan
HAHilal Ahmed
Hilal Ahmed
IAImtiaz Ahmed
Imtiaz Ahmed
SASalman Akhtar
Salman Akhtar
SAShafat Ali
Shafat Ali
PYPriyanka Yadav
Priyanka Yadav

10 March 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
MJMohd Rizwan Jameel
Mohd Rizwan Jameel
HJHina Jameel
Hina Jameel
SMSaad Mustafa
Saad Mustafa
MKMohd Faisal Khan
Mohd Faisal Khan
MMMohammad Misbah
Mohammad Misbah
Erythrocytes are the most plentiful cells of the human body with desirable morphologic and physiologic characteristics and their function in drug delivery has been exploited comprehensively. These cellular carriers, containing significant biodegradability, biocompatibility, and duration in circulation, can be burdened by a wide spectrum of compounds of therapeutic interest Carrier erythrocytes holding drugs, enzymes or peptides, Cas, and Nanoparticles can be used as a delivery system that approval to changes in the kinetic behavior and selective bio-distribution of the substances encapsulated. Carrier erythrocytes have been exploited for numerous potential applications, including the intravenous slow release of drug targeting, therapeutic agents and enzyme therapy to a reticuloendothelial system (RES). Hypotonic dialysis is the process most usually utilized in the formation of erythrocytes of carrier, however many features concern the give up and the erythrocytes ghost characteristics obtained with this technique. Attempt was also completed observe but erythrocyte regular release entrapped substances/antigens with additional entrapment in the plasma beads, improves the protein immunogenicity. The glycoenzyme invertase of large molecular weight was utilized a model substance and entrapment of invertase consummate with the dialysis method. Enzyme entrapment was examined in derived erythrocytes from rabbits, goats and human. Intended for the immunological studies were used in the rabbits. Invertase entrapped erythrocytes rabbit, where point out was additional encapsulated in the plasma beads and a contrast of immunogenicity of lose invertase, entrapped invertase in erythrocytes and that entrapped in RBCs and additional in encapsulated the plasma beads were examined. Antibodies production was investigated are different periods such as 12, 20, 20 and 35 days.

18 March 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
MJMohd Rizwan Jameel
Mohd Rizwan Jameel
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)/Cas9 (CRISPR-associated system) is used to edit specific genomic sequences with precision and efficacy. CRISPR/Cas9 system mediated double strand binding site through error-prone non homologous end joining repair in targeted sequences, which the deletion or insertion can be achieved by knock out gene. Creation advance construct of CRISPR/Cas9 of soluble starch synthase II-1, 2 and 3 ( SSSII ) genes in single destination binary vector through multi round LR reaction of Gateway technology. Gateway cloning system developed the suitable for the site-specific DNA recombination of lambda-bacteriophage and ccdB the cytotoxic protein, which is poisonous to most E. coli strains. A genetic transformation vector designed with appropriate gRNAs, Cas9, and antibiotic resistance was used to create SSSII knockout mutants.